Invesco’s AIM ImmunoTech AIM Stock Holding History

Invesco’s Portfolio AIM Stock Details AIM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-3	Closed	-$2K	–	3988
2018 Q4	$2K	Hold	3	–	–	﹤0.01%	3810
2018 Q3	$3K	Hold	3	–	–	﹤0.01%	3883
2018 Q2	$4K	Buy	+3	New	+$4.39K	﹤0.01%	3871

Other funds holding AIM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

OAM

Occidental Asset Management Burlingame, California $1.01B AUM 29.59% 1-Year Est. Return

TSS

Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return

RIA

Realta Investment Advisors Wilmington, Delaware $322M AUM 39.45% 1-Year Est. Return

WPW

Waldron Private Wealth Bridgeville, Pennsylvania $2.89B AUM 23.18% 1-Year Est. Return

Invesco's AIM Position: Q1 2019 in Review

Invesco sold out of AIM ImmunoTech (AIM) in Q1 2019, closing a stake of 3 shares — an estimated $2K sold.

Invesco first reported a position in AIM in Q2 2018 and held it in 3 quarters. The position peaked at $4K in Q2 2018. 12 funds tracked by Wall St. Rank hold AIM as of Q1 2019.

Invesco reported no remaining AIM ImmunoTech position as of Q1 2019 after selling out during the quarter.
Invesco sold 3 AIM ImmunoTech shares in Q1 2019, an estimated $2K.
Invesco first reported a position in AIM ImmunoTech in Q2 2018 and held it in 3 quarters.
Invesco's AIM ImmunoTech position peaked at $4K in Q2 2018.
12 funds tracked by Wall St. Rank held AIM ImmunoTech as of Q1 2019.

Based on Invesco's 13F filing for Q1 2019, filed 15 May 2019.